Pully System Exercise Role in Management of Spasticity

June 19, 2025 updated by: Sara Yousef Abdel Elglil Yousef Elsebahy, Kafrelsheikh University

Effect of Pully System Exercise in Management of Spasticity in Cerebral Palsy Children: A Randomized Clinical Trial

The goal of this clinical trial is to investigate the effect of pully system exercise in in management of spasticity in cerebral palsy children

Does pully system exercise has role in management of spasticity in cerebral palsy children ?

Participants will:

The participants assigned to the control group will receive a standard care program. This program is designed to provide basic supportive therapies without the specialized pulley system exercises

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

there are two groups one group will receive traditional physical therapy programme another group will receive pully system exercise

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Tanta, Egypt
        • Elsalam university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Inclusion criteria
  • The degree of spasticity is (1) according to Modified Ashwarth's scale
  • They able to understand orders given to them.
  • All children evaluated before and after the suggested period of the physical therapy program (3months).

Exclusion Criteria:

  • - No fixed deformities.
  • They have neither visual nor auditory problems.
  • They have neither perceptual nor cognitive problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group 1
the l group will receive a standard care program.
Other: designed physical therapy , pully system exercise
Participants assigned to the intervention group will engage in a specially designed physical therapy program focusing on pulley system exercises. The program is scheduled to occur three times per week, which is frequent enough to potentially induce meaningful improvements while allowing adequate rest between sessions to prevent fatigue and overtraining
Experimental: study
study group will received pulley system exercises
Other: designed physical therapy , pully system exercise
Participants assigned to the intervention group will engage in a specially designed physical therapy program focusing on pulley system exercises. The program is scheduled to occur three times per week, which is frequent enough to potentially induce meaningful improvements while allowing adequate rest between sessions to prevent fatigue and overtraining

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gross motor function of children with cerebral palsy using GMFMS
Time Frame: 3 months
evaluate change that occurs over time in the gross motor function of children with cerebral palsy
3 months
pediatric balance scale
Time Frame: 3 months
A 14-item criterion-referenced measure that examines functional balance in the context of everyday tasks in the pediatric population.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
spasticity with EMG
Time Frame: 3 months
In assessing muscle tone it is important to consider all the inputs and outputs affecting it, using biomechanical-EMG techniques for measuring active tone
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
erobic capacity
Time Frame: 3 months
6m walk test
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kafrelsheikh University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2025

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

April 12, 2025

First Posted (Actual)

April 15, 2025

Study Record Updates

Last Update Posted (Estimated)

June 25, 2025

Last Update Submitted That Met QC Criteria

June 19, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KFSIRB200-193

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on designed physical therapy , pully system exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe